| Dr Elizabeth Mott, MD | |
|
Po Box 430, Onancock, VA 23417-0430 | |
| (757) 302-2100 | |
| Not Available |
| Full Name | Dr Elizabeth Mott |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 11 Years |
| Location | Po Box 430, Onancock, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275956443 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 0101262930 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Shore Memorial Hospital | Onancock, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Physician Services Inc | 5092608448 | 743 |
News Archive
Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies - from electronic medical records to genetic testing - that are changing the way medicine is practiced.
Before they leave for the Memorial Day recess, lawmakers face legislation which includes a provision on Medicare payments to physicians and an extension of the COBRA subsidy to newly laid-off workers.
Sigma-Aldrich Corporation today announced that Sigma Life Science, its innovative biological products and services business, released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly.
What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.
› Verified 7 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies - from electronic medical records to genetic testing - that are changing the way medicine is practiced.
Before they leave for the Memorial Day recess, lawmakers face legislation which includes a provision on Medicare payments to physicians and an extension of the COBRA subsidy to newly laid-off workers.
Sigma-Aldrich Corporation today announced that Sigma Life Science, its innovative biological products and services business, released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly.
What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Mott, MD 856 J Clyde Morris Blvd Ste A, Newport News, VA 23601-1318 Ph: (757) 316-5900 | Dr Elizabeth Mott, MD Po Box 430, Onancock, VA 23417-0430 Ph: (757) 302-2100 |
News Archive
Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies - from electronic medical records to genetic testing - that are changing the way medicine is practiced.
Before they leave for the Memorial Day recess, lawmakers face legislation which includes a provision on Medicare payments to physicians and an extension of the COBRA subsidy to newly laid-off workers.
Sigma-Aldrich Corporation today announced that Sigma Life Science, its innovative biological products and services business, released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly.
What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.
› Verified 7 days ago
Dr. Ahmed Mustafa Ali Younes, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 20480 Market St, Onancock, VA 23417 Phone: 757-302-2100 | |
Dr. Alex Zawoloka, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20480 Market St, Onancock, VA 23417 Phone: 757-302-2100 Fax: 757-302-2343 |